BridgeBio Pharma, Inc. (BIT:1BBIO)
Italy · Delayed Price · Currency is EUR 47.23
0.00 (0.00%)
At close: Oct 10, 2025
BridgeBio Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| 235.81 | 221.9 | 9.3 | 77.65 | 69.72 | 8.25 | Upgrade | |
Revenue Growth (YoY) | 7.62% | 2285.27% | -88.02% | 11.38% | 745.14% | -79.66% | Upgrade |
Cost of Revenue | 8.97 | 3.88 | 2.45 | 3.43 | 3.11 | - | Upgrade |
Gross Profit | 226.84 | 218.02 | 6.86 | 74.21 | 66.6 | 8.25 | Upgrade |
Selling, General & Admin | 399.12 | 288.93 | 150.59 | 143.19 | 192.21 | 145.68 | Upgrade |
Research & Development | 473.46 | 506.46 | 455.71 | 399.46 | 451.02 | 337.05 | Upgrade |
Other Operating Expenses | 10.69 | 15.61 | 7.93 | 43.77 | - | - | Upgrade |
Operating Income | -656.43 | -592.97 | -607.37 | -512.2 | -576.63 | -474.48 | Upgrade |
Interest Income | 17.26 | 17.25 | 18.04 | 7.54 | 1.13 | 4.02 | Upgrade |
Interest Expense | - | -99.29 | -81.29 | -80.44 | -46.78 | -36.66 | Upgrade |
Other Non-Operating Income (Expense) | 18.2 | 217.18 | 17.37 | 100.45 | 35.82 | 1.63 | Upgrade |
Total Non-Operating Income (Expense) | 35.46 | 135.14 | -45.88 | 27.55 | -9.82 | -31.01 | Upgrade |
Pretax Income | -620.97 | -542.19 | -653.25 | -484.65 | -586.45 | -505.49 | Upgrade |
Provision for Income Taxes | - | 1.15 | - | - | - | - | Upgrade |
Net Income | -776.42 | -535.76 | -643.2 | -481.18 | -562.54 | -448.72 | Upgrade |
Minority Interest in Earnings | -50.41 | -23.6 | 10.05 | 3.47 | 23.92 | 56.76 | Upgrade |
Net Income to Common | -776.42 | -535.76 | -643.2 | -481.18 | -562.54 | -448.72 | Upgrade |
Shares Outstanding (Basic) | 190 | 186 | 163 | 147 | 144 | 118 | Upgrade |
Shares Outstanding (Diluted) | 190 | 186 | 163 | 147 | 144 | 118 | Upgrade |
Shares Change (YoY) | 7.75% | 14.30% | 10.39% | 2.16% | 22.34% | 12.27% | Upgrade |
EPS (Basic) | -4.11 | -2.88 | -3.95 | -3.26 | -3.90 | -3.80 | Upgrade |
EPS (Diluted) | -4.11 | -2.88 | -3.95 | -3.26 | -3.90 | -3.80 | Upgrade |
Free Cash Flow | -656.59 | -521.66 | -529.03 | -424.32 | -511.18 | -407.23 | Upgrade |
Free Cash Flow Per Share | -3.46 | -2.80 | -3.25 | -2.88 | -3.54 | -3.45 | Upgrade |
Gross Margin | 96.19% | 98.25% | 73.71% | 95.58% | 95.53% | 100.00% | Upgrade |
Operating Margin | -278.37% | -267.22% | -6528.75% | -659.65% | -827.12% | -5751.99% | Upgrade |
Profit Margin | -332.90% | -244.86% | -7021.94% | -624.17% | -841.20% | -6127.87% | Upgrade |
FCF Margin | -278.44% | -235.09% | -5686.62% | -546.46% | -733.23% | -4936.74% | Upgrade |
EBITDA | -650.92 | -586.9 | -600.88 | -505.43 | -570.79 | -473.03 | Upgrade |
EBITDA Margin | -276.03% | -264.49% | -6458.95% | -650.93% | -818.73% | -5734.34% | Upgrade |
EBIT | -656.43 | -592.97 | -607.37 | -512.2 | -576.63 | -474.48 | Upgrade |
EBIT Margin | -278.37% | -267.22% | -6528.75% | -659.65% | -827.12% | -5751.99% | Upgrade |
Effective Tax Rate | 0.00% | -0.21% | 0.00% | 0.00% | 0.00% | 0.00% | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.